Clinical Trials Sponsored by The Pregene (ShenZhen) Biotechnology Company, Ltd.

Total 22 results

Shenzhen Second People's Hospital
The Pregene (ShenZhen) Biotechnology Company, Ltd.

Unknown

EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer (EGFRCART)

Metastatic Colorectal Cancer

China
Henan Cancer Hospital
The Pregene (ShenZhen) Biotechnology Company, Ltd.

Unknown

BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Myeloma

China
Henan Cancer Hospital
The Pregene (ShenZhen) Biotechnology Company, Ltd.

Unknown

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

Relapsed Non Hodgkin Lymphoma

China
Henan Cancer Hospital
The Pregene (ShenZhen) Biotechnology Company, Ltd.

Unknown

Study of BCMA CAR-T in Multiple Myeloma

Multiple Myeloma

China
Henan Cancer Hospital
The Pregene (ShenZhen) Biotechnology Company, Ltd.

Unknown

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

B-cell Acute Lymphocytic Leukemia

China
The Pregene (ShenZhen) Biotechnology Company, Ltd.
Henan Cancer Hospital

Unknown

BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma (BCMA CAR-T)

Relapsed and Refractory Multiple Myeloma

China
Shenzhen Second People's Hospital
The Beijing Pregene Science and Technology Company, Ltd.

Unknown

EGFR CART Cells for Patients With Metastatic Colorectal Cancer

EGFR-positive Colorectal Cancer

China
Shenzhen Second People's Hospital
The Beijing Pregene Science and Technology Company, Ltd.

Unknown

CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.

B Cell Lymphoma

China
Henan Cancer Hospital
The Beijing Pregene Science and Technology Company, Ltd.

Unknown

The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma

B Cell Lymphoma

China
Henan Cancer Hospital
The Beijing Pregene Science and Technology Company, Ltd.

Unknown

The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).

B-cell Acute Lymphoblastic Leukemia

China
Shenzhen Hornetcorn Bio-technology Company, LTD
The Fifth Affiliated Hospital of Guangzhou Medical University

Completed

Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect

Osteoarthritis | Cartilage Diseases

China
Shenzhen Hornetcorn Bio-technology Company, LTD
The Fifth Affiliated Hospital of Guangzhou Medical University

Unknown

Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela

Cerebral Hemorrhage

China
Shenzhen Hornetcorn Bio-technology Company, LTD
The Second Affiliated Hospital of University of South China

Unknown

Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis

Pneumoconiosis

China
Shenzhen Hornetcorn Bio-technology Company, LTD
The Second Affiliated Hospital of University of South China

Unknown

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Hepatic Cirrhosis

China
The 458 Hospital of Chinese PLA
Guangzhou Baidi Biotechnology Co., Ltd; Guangzhou Pharmaceucal Company Limited

Unknown

A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B

Chronic Hepatitis B Patients With HBeAg-positive

China
iCell Gene Therapeutics
The General Hospital of Western Theater Command; Peking University Shenzhen... and other collaborators

Recruiting

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myeloid Leukemia | Hematologic Malignancy | Myeloproliferative Neoplasm

China
Xinqiao Hospital of Chongqing
Chongqing University Cancer Hospital; 920th Hospital of Joint Logistics Support... and other collaborators

Not yet recruiting

CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL

B-cell Lymphoma Refractory | B-cell Lymphoma Recurrent

China
Xinqiao Hospital of Chongqing
The First Affiliated Hospital of Anhui Medical University; Chongqing University... and other collaborators

Unknown

Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

B Cell Leukemia | Relapsed Adult ALL

China
Xinqiao Hospital of Chongqing
The First Affiliated Hospital of Anhui Medical University; Nanfang Hospital... and other collaborators

Recruiting

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

T-cell Lymphoma | T-cell Leukemia

China
Xinqiao Hospital of Chongqing
The First Affiliated Hospital of Anhui Medical University; Nanfang Hospital... and other collaborators

Unknown

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

B-cell Lymphoma | B-cell Acute Lymphoblastic Leukemia

China
GeneCast Biotechnology Co., Ltd.
Wuhan University; Southwest Hospital, China; Tongji Hospital; The First Affiliated... and other collaborators

Terminated

Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION) (MOTIVATION)

Non-small Cell Lung Cancer | Biomarker | Next-generation Sequencing | Neoantigen

China
Peking University Third Hospital
The Second Hospital of Hebei Medical University; First Affiliated Hospital,... and other collaborators

Recruiting

Embryo Selection by Noninvasive Preimplantation Genetic Test (ESNi-PGT)

Infertility | Chromosome Abnormality

China

Clinical Trials Sponsored by The Pregene (ShenZhen) Biotechnology Company, Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations